MedPath

VYALEV

VYALEV

Approved
DIN Number

02537702

Drug Class

Human

Market Date

Feb 5, 2024

Company
HC

Abbvie Corporation

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02537702
AIG Number0264641001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
N04BA07 FOSLEVODOPA AND DECARBOXYLASE INHIBITOR
Product Specifications
Dosage FormSolution
Route of AdministrationSubcutaneous
AHFS Classification28:36.16
Health Canada Classification

ACTIVE INGREDIENTS (2)

FOSCARBIDOPAActive
Strength: 12 MG / ML
Monograph: FOSCARBIDOPA
FOSLEVODOPAActive
Strength: 240 MG / ML
Monograph: FOSLEVODOPA

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.